The i4i PRODICT® study has been developed to investigate the uptake and acceptability of the i4i PRODICT® test which combines both common and rare genetic changes (genetic variants) into one saliva-based DNA test to estimate a person's future risk of prostate cancer (PrCa) in people of varying ethnicities.
People with a prostate* (PwP). *People with a prostate is defined as people born male.
Aged 40 to 55 years.
People of either (i) Black African/Black African-Caribbean; (ii) White European; or (iii) South Asian or East Asian ancestry. These are defined as individuals with 4 grandparents of the same ancestry.
Absence of any psychological, familial, sociological or geographical situation potentially hampering compliance with the study protocol and follow-up schedule.
Previous diagnosis of prostate cancer.
People of mixed ancestry
Previous diagnosis of cancer with a life-expectancy of less than five years.
Negative prostate biopsy within one year before recruitment.
Institute of Cancer Research, United Kingdom
Lead sponsor
Royal Marsden NHS Foundation Trust
Collaborator
Imperial College London
Collaborator